Walnut Oral Immunotherapy for Tree Nut Allergy

Summary

Walnut Oral Immunotherapy for Tree Nut Allergy is a clinical trial^[1].

Key Facts

• Walnut Oral Immunotherapy for Tree Nut Allergy is in the country of United States^[2].
• Walnut Oral Immunotherapy for Tree Nut Allergy's instance of is recorded as clinical trial^[3].
• Walnut Oral Immunotherapy for Tree Nut Allergy's start time is recorded as +2012-04-27T00:00:00Z^[4].
• Walnut Oral Immunotherapy for Tree Nut Allergy's end time is recorded as +2020-04-30T00:00:00Z^[5].
• Walnut Oral Immunotherapy for Tree Nut Allergy's sponsor is recorded as University of Arkansas^[6].
• Walnut Oral Immunotherapy for Tree Nut Allergy's main subject is recorded as hypersensitivity^[7].
• Walnut Oral Immunotherapy for Tree Nut Allergy's number of participants is recorded as {'unit': '1', 'amount': '+22'}^[8].
• Walnut Oral Immunotherapy for Tree Nut Allergy's title is recorded as Walnut Oral Immunotherapy for Tree Nut Allergy^[9].
• Walnut Oral Immunotherapy for Tree Nut Allergy's short name is recorded as WOIT^[10].
• Walnut Oral Immunotherapy for Tree Nut Allergy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+6'}^[11].
• Walnut Oral Immunotherapy for Tree Nut Allergy's ClinicalTrials.gov ID is recorded as NCT01546753^[12].
• Walnut Oral Immunotherapy for Tree Nut Allergy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[13].
• Walnut Oral Immunotherapy for Tree Nut Allergy's clinical trial phase is recorded as phase I clinical trial^[14].
• Walnut Oral Immunotherapy for Tree Nut Allergy's clinical trial phase is recorded as phase II clinical trial^[15].
• Walnut Oral Immunotherapy for Tree Nut Allergy's research site is recorded as Arkansas Children's Hospital^[16].
• Walnut Oral Immunotherapy for Tree Nut Allergy's study type is recorded as interventional study^[17].